Back to Search
Start Over
Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs
- Source :
- Pharmacoeconomics, 39(2), 257-269. ADIS INT LTD, Pharmacoeconomics
- Publication Year :
- 2021
-
Abstract
- Background Assessing the societal perspective in economic evaluations of new interventions requires estimates of indirect non-medical costs caused by the disease. Different methods exist for measuring the labor input function as a surrogate for these costs. They rarely specify the effect of health on labor and who gains and who loses money. Social accounting matrix (SAM) is an established framework that evaluates public policies with multiple perspectives that could help. Objectives We evaluated the use of a modified SAM to assess money flows between different economic agents resulting in economic transactions following policy changes of medical interventions. Methods We compared conventional methods of measuring indirect non-medical costs related to rotavirus vaccination in the Netherlands with a modified SAM framework. To compare the outcome of each method, we calculated returns on investment (ROI) as the net amount of money per euro invested in the vaccine. One-way and probabilistic sensitivity analyses were carried out for each method, focusing on critical variables with the largest impact on indirect cost estimates. Results The ROI was higher for the modified SAM (1.33) than for the conventional methods assessing income calculations (range - 0.178 to 1.22). Probabilistic sensitivity analyses showed wide distributions in the ROI estimates, with variation in the variable impact on the indirect cost results per method selected. Conclusions In contrast to conventional methods, the SAM approach provides detailed and comprehensive assessments of the impact of new interventions on the indirect non-medical costs and the financial interactions between agents, disclosing useful information for different stakeholders.
- Subjects :
- IMPACT
Cost-Benefit Analysis
Public policy
03 medical and health sciences
Indirect costs
0302 clinical medicine
ROTAVIRUS VACCINATION
Health care
Economics
Econometrics
Humans
Original Research Article
030212 general & internal medicine
PERSPECTIVE
health care economics and organizations
Netherlands
Pharmacology
INCOME
Health economics
PRODUCTIVITY COSTS
business.industry
030503 health policy & services
Health Policy
Vaccination
Public Health, Environmental and Occupational Health
Probabilistic logic
Investment (macroeconomics)
Variable (computer science)
ECONOMIC EVALUATIONS
HEALTH-CARE
0305 other medical science
business
Social accounting matrix
Subjects
Details
- Language :
- English
- ISSN :
- 11707690
- Database :
- OpenAIRE
- Journal :
- Pharmacoeconomics, 39(2), 257-269. ADIS INT LTD, Pharmacoeconomics
- Accession number :
- edsair.doi.dedup.....203ec04e60a5d374108d5d654678538c